Revista espanola de enfermedades digestivas
Effect of vedolizumab treatment on extraintestinal articular manifestations in patients with inflammatory bowel disease: meta-analysis.
Diego Casas-Deza, Carmen Yagüe-Caballero, Camila Cuarán Cetina, Santiago García-López
Published: 202510.17235/reed.2025.11419/2025
Abstract
INTRODUCTION: Joint extraintestinal manifestations (EIMs) are a frequent complication in patients with inflammatory bowel disease (IBD). The effectiveness of vedolizumab in this context remains uncertain, with conflicting results reported. Some studi…
Preview only. Read the full abstract at the source